Many members in this group know how stressful PSA tests and biopsies can be, not just at diagnosis but also during follow-ups. Some biopsies confirm aggressive cancer that needs treatment, while others detect slow-growing cancers that might only need monitoring. However, biopsies aren’t easy, they can be painful, carry risks of infection, and add to the emotional burden of managing prostate cancer.
A new urine-based test,MyProstateScore 2.0 (MPS2), was recently developed to help doctors distinguish between aggressive and low-risk prostate cancers more accurately. In studies, this test:
✔️ Ruled out aggressive cancer with 97% accuracy
✔️ Could help reduce unnecessary biopsies by up to 51%
✔️ May offer a less invasive new tool for follow-up care and monitoring
This raises some important questions:
For those monitoring their cancer, would this test make you feel more confident in avoiding unnecessary biopsies?
For those who’ve undergone multiple biopsies, how do you feel about a potential non-invasive option?
Do you think new tests like this could improve how prostate cancer is managed long-term?
Somya.P
Community managerGood advisor
Somya.P
Community manager
Last activity on 05/02/2025 at 12:16
Joined in 2023
494 comments posted | 10 in the Living with prostate cancer group
44 of their responses were helpful to members
Rewards
Good Advisor
Contributor
Messenger
Explorer
Friend
Hello everyone,
How are you feeling today?
Many members in this group know how stressful PSA tests and biopsies can be, not just at diagnosis but also during follow-ups. Some biopsies confirm aggressive cancer that needs treatment, while others detect slow-growing cancers that might only need monitoring. However, biopsies aren’t easy, they can be painful, carry risks of infection, and add to the emotional burden of managing prostate cancer.
A new urine-based test, MyProstateScore 2.0 (MPS2), was recently developed to help doctors distinguish between aggressive and low-risk prostate cancers more accurately. In studies, this test:
✔️ Ruled out aggressive cancer with 97% accuracy
✔️ Could help reduce unnecessary biopsies by up to 51%
✔️ May offer a less invasive new tool for follow-up care and monitoring
This raises some important questions:
For those monitoring their cancer, would this test make you feel more confident in avoiding unnecessary biopsies?
For those who’ve undergone multiple biopsies, how do you feel about a potential non-invasive option?
Do you think new tests like this could improve how prostate cancer is managed long-term?
@Eddyyy @Peters @dennit @carmen @instructor @jarrah @Tazionuv694 @del123boy @rosco8 @spartikas58 @Bootneck @popodoc @gandusala @terry7777 @Geordie61 @sexydevil @Robert Sayell @pauly59 @dennis @Henery @Eilybobs @rockview @eoin17 @stardust @makeandmend @ anderson_chloe @andrew54 @jonny27 @Wallnut @Michael1956 @cooperman @topman1001` @ddawnninja @jellies @JFT787L @Challenger @toddy1234 @davidvon @patrick.kennedy20 @Philwood @dave2212 @melarcher @GRobbins @Zaaroura @carbuilder @bernardxx @Swanvesta @paulcouldwell @richard1949 @Ringo1026 @David43 @StevieB68 @davethediner @Richard46 @davehubbard @billy18 @johnglover @willie @Sundaze18 @tonybrown2118 @groeslon @johnmj @simonflys @drake69 @rcgough @Elbowjoe @Robert.t @AJWilson @stringer2948 @mmcveigh @lagangreene @johnpaul1946 @Oscair66 @katlin @Padriag @Coolcarbon @prostatepete @Romanser @pompey @billhellings @Ianbeat @michaellate @Reggie56 @Fairyjan @exraymond @Hotdog12 @markonthemend @Loraine58 @Polly787 @styver @Peanut07 @judahtwo @Wales67 @Dazzer65 @skulamus @Annabella56 @CaptainMike @pratapmehta @Meltonmark @Igwefrank24
Would love to hear your thoughts and experiences, especially from those managing their PSA levels post-treatment! 💬
Take care,
Somya from the Carenity team 🌼